These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16858571)

  • 21. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study.
    Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC
    J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transurethral needle ablation (TUNA): thermal gradient mapping and comparison of lesion size in a tissue model and in patients with benign prostatic hyperplasia.
    Rasor JS; Zlotta AR; Edwards SD; Schulman CC
    Eur Urol; 1993; 24(3):411-4. PubMed ID: 7505227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TUNA of the prostate in an office setting: nursing implications.
    Parrott EK
    Urol Nurs; 2003 Feb; 23(1):33-9; quiz 40. PubMed ID: 12677718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia.
    Boyle P; Robertson C; Vaughan ED; Fitzpatrick JM
    BJU Int; 2004 Jul; 94(1):83-8. PubMed ID: 15217437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advances in minimally invasive treatment of benign prostatic hyperplasia].
    Yu B; Wang Z
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):739-43. PubMed ID: 17918717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of the efficacy and safety of transurethral needle ablation (TUNA) treatment for benign prostatic hyperplasia.
    Millard RJ; Harewood LM; Tamaddon K
    Neurourol Urodyn; 1996; 15(6):619-28; discussion 628-9. PubMed ID: 8916114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study.
    Ramon J; Lynch TH; Eardley I; Ekman P; Frick J; Jungwirth A; Pillai M; Wiklund P; Goldwasser B; Fitzpatrick JM
    Br J Urol; 1997 Jul; 80(1):128-34; discussion 134-5. PubMed ID: 9240192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transurethral resection versus minimally invasive treatments of benign prostatic hyperplasia: results of treatments. Our experience.
    Minardi D; Galosi AB; Yehia M; Cristalli A; Hanitzsch H; Polito M; Muzzonigro G
    Arch Ital Urol Androl; 2004 Mar; 76(1):11-8. PubMed ID: 15185816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transurethral Needle Ablation of the prostate (TUNA): clinical results and ultrasound, endoscopic, and histologic findings in pilot study of patients in urinary retention.
    Harewood LM; Cleeve LK; O'Connell HE; Pope AJ; Vaughan MG; Agarwal D
    J Endourol; 1995 Oct; 9(5):407-12. PubMed ID: 8580942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimally invasive surgery in the management of benign prostatic hyperplasia.
    Berardinelli F; Hinh P; Wang R
    Minerva Urol Nefrol; 2009 Sep; 61(3):269-89. PubMed ID: 19773728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two-years follow-up of radiofrequency thermotherapy for urination disorders due to benign prostatic hyperplasia].
    Savoie PH; Lopez L; Simonin O; Loubat M; Bladou F; Serment G; Karsenty G
    Prog Urol; 2009 Jul; 19(7):501-6. PubMed ID: 19559382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
    Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
    BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [5-year follow-up to transurethral vaporesection of the prostate using the 2 micron continuous wave laser for the treatment of benign prostatic hyperplasia].
    Xu Y; Sun DC; Yang Y; Wei ZT; Hong BF; Zhang X
    Zhonghua Wai Ke Za Zhi; 2013 Feb; 51(2):119-22. PubMed ID: 23711003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newly developed equipment and methods in the treatment of BPH: analysis of present status.
    Tazaki H; Baba S; Nakamura K; Tachibana M; Nakashima J; Nakagawa K; Deguchi N
    Int J Urol; 1996 Jan; 3(1 Suppl):S48-52. PubMed ID: 24304024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transurethral needle ablation of the prostate: a minimally invasive treatment for symptomatic benign prostatic hyperplasia.
    Beduschi MC; Oesterling JE
    Mayo Clin Proc; 1998 Jul; 73(7):696-701. PubMed ID: 9663202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
    McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
    Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.